BioSpace News Archive

Deals

AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stock in a registered direct offering at a purchase price of $0.363 per share.

May 31, 2024
·
4 min read
Increase of Number of Shares and Votes in Vicore Pharma

Vicore Pharma Holding AB announced that the number of Vicore shares and votes has increased following the exercise of warrants with subsequent delivery of shares to a participant in the incentive program Board LTIP 2023.

May 31, 2024
·
2 min read
Deals

Soligenix Announces Reverse Stock Split - May 31, 2024

Soligenix, Inc. announced today that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 16 pre-split shares.

May 31, 2024
·
7 min read
Biotech Bay

Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024

Protagonist Therapeutics, Inc. today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York City on June 4-6, 2024.

May 31, 2024
·
2 min read
Genetown

Morphic to Participate in Jefferies Global Healthcare Conference

Morphic Therapeutic today announced that members of its management team will take part in a fireside chat at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5th, at 10:30 AM ET.

May 31, 2024
·
1 min read
Biotech Beach

Agendia Announces New Data Assessing the Immune Active State in HR+/HER2- Early-Stage Breast Cancer at 2024 ASCO

Agendia ® , Inc. today announced it will present new data characterizing the immune biology of MammaPrint High Risk tumors in an oral session at the 2024 Annual American Society of Clinical Oncology (ASCO) Meeting , taking place in Chicago, IL. on June 3rd, 2024.

May 31, 2024
·
5 min read
Biotech Beach

MBrace Therapeutics Presents Trial in Progress Poster for Lead Antibody-Drug Conjugate Program at 2024 ASCO Annual Meeting

MBrace™ Therapeutics, Inc. today announced that the Company will be presenting a Trial in Progress (TIP) poster at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, being held from May 31-June 4, 2024, in Chicago, Illinois.

May 31, 2024
·
3 min read
Pharm Country

Quantum-Si Announces Presentations at ASMS and ESHG

Quantum-Si Incorporated today announced presentations at two upcoming industry conferences.

May 31, 2024
·
2 min read
Biotech Beach

Masimo Announces Nomination of Independent Candidate to the Board of Directors

Masimo (NASDAQ: MASI) announced today that its Board of Directors has nominated Christopher Chavez for election as a Class II Director at the Company’s 2024 Annual Meeting.

May 31, 2024
·
7 min read
Drug Development

Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial

Hansa Biopharma AB, (“Hansa” or the “Company”) (NASDAQ Stockholm: HNSA), today announced recruitment and randomization in its US ConfIdeS trial is complete.

May 31, 2024
·
8 min read